• Citer

Pin1: a therapeutic target in Alzheimer neurodegeneration.

par Hamdane, Malika ;Smet, Caroline;Sambo, Anne-Véronique;Leroy, Arnaud;Wieruszeski, Jean-Michel;Delobel, Patrice;Maurage, Claude-Alain;Ghestem, Antoine;Wintjens, René ;Bégard, Séverine;Sergeant, Nicolas;Delacourte, André;Horvath, Dragos;Landrieu, Isabelle;Lippens, Guy;Buée, Luc
Référence Journal of molecular neuroscience, 19, 3, page (275-287)
Publication Publié, 2002-12

Article révisé par les pairs

• Détails
• Contenu

Résumé :

In Alzheimer's disease, the peptidyl prolyl cis/trans isomerase Pin1 binds to phospho-Thr231 on Tau proteins and, hence, is found within degenerating neurons, where it is associated to the large amounts of abnormally phosphorylated Tau proteins. Conversely, Pin1 may restore the tubulin polymerization function of these hyperphosphorylated Tau. In the present work, we investigated, both at the cellular and molecular levels, the role of Pin1 in Alzheimer's disease through the study of its interactions with phosphorylated Tau proteins. We also showed that in neuronal cells, Pin1 upregulates the expression of cyclin D1. This, in turn, could facilitate the transition from quiescence to the G1 phase (re-entry in cell cycle) in a neuron and, subsequently, neuronal dedifferentiation and apoptosis. The involvement of Pin1 in the G0/G1 transition in neurons points to its function as a good target for the development of new therapeutic strategies in neurodegenerative disorders.